gemfibrozil

Key facts

INN

gemfibrozil

Brand

LOPID

Route

ORAL

Formulation

CAPSULE

Originator

TEVA PHARMACEUTICAL INDUSTRIES LTD

Related patents

patent

US 11642335

Chemical synthesis of clopidogrel active metabolites and disulfide conjugate pro

Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9889125

Methods for treating heartburn, gastric bleeding or hemorrhage in patients recei

Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9233103

Methods for treating heartburn, gastric bleeding or hemorrhage in patients recei

Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 7259261

Racemization and enantiomer separation of clopidogrel

Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 6800759

Racemization and enantiomer separation of clopidogrel

Expires Mon Sep 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 6737411

Racemization and enantiomer separation of clopidogrel

Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is gemfibrozil?

gemfibrozil (LOPID), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

What is the brand name for gemfibrozil?

LOPID is a marketed brand name for gemfibrozil. Check FDA Drugs@FDA for the current US label holder.